These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14887229)

  • 1. [New form of insulin: crystallized protamine insulin (NPH 50)].
    RUDOLF M
    Concours Med; 1951 Nov; 73(45):3755-7. PubMed ID: 14887229
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insulin with retarded and prolonged action: a new preparation: crystallized protamine insulin NPH 50].
    AUBERTIN E
    J Med Bord; 1951 Jul; 128(7):716-20. PubMed ID: 14861556
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural characterization of insulin NPH formulations.
    Norrman M; Hubálek F; Schluckebier G
    Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with a new modified protamine insulin (NPH-50).
    GABRIELE AJ; MARBLE A
    Am J Dig Dis; 1949 Jun; 16(6):197-206. PubMed ID: 18129669
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes.
    Levy JH; Zaidan JR; Faraj B
    Anesth Analg; 1986 Jul; 65(7):739-42. PubMed ID: 2424341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified protamine insulin (NPH-50) a clinical report.
    WHITE P
    J Am Med Assoc; 1949 Oct; 141(5):312-4. PubMed ID: 18148369
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural studies of a crystalline insulin analog complex with protamine by atomic force microscopy.
    Yip CM; Brader ML; Frank BH; DeFelippis MR; Ward MD
    Biophys J; 2000 Jan; 78(1):466-73. PubMed ID: 10620310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
    DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
    J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
    Yanagisawa K
    Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis to protamine masquerading as an insulin allergy.
    Kim R
    Del Med J; 1993 Jan; 65(1):17-23. PubMed ID: 8454092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protamine sulfate and NPH insulin.
    Veenendaal M
    Cathet Cardiovasc Diagn; 1988; 15(2):134. PubMed ID: 3180206
    [No Abstract]   [Full Text] [Related]  

  • 13. Allergic shock and death associated with protamine administration in a diabetic patient.
    Chu YQ; Cai LJ; Jiang DC; Jia D; Yan SY; Wang YQ
    Clin Ther; 2010 Sep; 32(10):1729-32. PubMed ID: 21194595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate and long-acting insulin preparations without protamine sulphate are complement activators in vitro.
    Duchateau J; Schreyen H; Dorchy H
    Diabete Metab; 1992; 18(4):272-6. PubMed ID: 1459314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics].
    Gao Y; Pan CY; Zou DJ; Xu ZR; Liu XM; Guo XH
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(28):1960-3. PubMed ID: 19950569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal anaphylactic reaction to protamine after femoropopliteal by-pass surgery.
    Hakala T; Suojaranta-Ylinen R
    Ann Chir Gynaecol; 2000; 89(2):150-2. PubMed ID: 10905682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactoid reactions to protamine: an often lethal complication in insulin-dependent diabetic patients undergoing vascular surgery.
    Gupta SK; Veith FJ; Ascer E; Wengerter KR; Franco C; Amar D; el-Gaweet ES; Gupta A
    J Vasc Surg; 1989 Feb; 9(2):342-50. PubMed ID: 2645443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions to protamine sulfate during cardiac surgery in diabetic and non-diabetic patients.
    Gottschlich GM; Gravlee GP; Georgitis JW
    Ann Allergy; 1988 Oct; 61(4):277-81. PubMed ID: 3177970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protamine-zinc-insulin in combination protamine-zinc-insulin with ordinary insulin in ambulatory treatment of diabetes mellitus].
    KOZDON A
    Prakt Lek; 1952 Jul; 32(14):321-6. PubMed ID: 14948801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.